IGM Biosciences, Inc. (IGMS) has a market capitalization of $77.5M and trades at $1.27. The 52-week range is 0.92-22.5.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of -0.4, Earnings Per Share (EPS) of $-3.24, annual revenue of $2.68M.
The stock has a beta of 0.59, operates in the Healthcare sector.
